Intensity Therapeutics Inc. (INTS) Live Share Price, Invest From India

Intensity Therapeutics Inc. Stock Performance

as on July 20, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.57
Day's Price Range
$4.80
$4.75
3.79%
Downside
1.05%
Upside
52 Week's Low
52 Week's High
$3.51
52-Week Price Range
$43.50
$4.75
26.11%
Downside
815.79%
Upside

Intensity Therapeutics Inc. share price movements today

Previous Close: $4.90
Open: $4.59
Volume: 255.6K
Day's Low - High: $4.57 - $4.80
52 Week Low - High: $3.51 - $43.50

Intensity Therapeutics Inc. Historical Returns

1 Month Return: + 21.17 %
3 Month Return: -8.92 %
1 Year Return: -41.54 %
3 Year Return: -96.87 %
5 Year Return: 0 %

Intensity Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Intensity Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.8M

EPS (TTM)

-3.1333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-207.37%

Intensity Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Intensity Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Intensity Therapeutics Inc.	BUY	$12.8M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.6B	515.2%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.3B	147.09%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.9B	15.23%	16.53	29.65%	0.53%

Stock Returns calculator for Intensity Therapeutics Inc. Stock including INR - Dollar returns

The Intensity Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Intensity Therapeutics Inc. investment value today

Current value as on today

₹65,342

Returns

-₹34,658

(-34.66%)

Returns from Intensity Therapeutics Inc. Stock

-₹41,502 (-41.5%)

Dollar Impact

₹6,844 (+6.84%)

Analyst Recommendation on Intensity Therapeutics Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Intensity Therapeutics Inc.. Average target price of $24.8

Intensity Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Intensity Therapeutics Inc..

What analysts predicted

80.85%UPSIDE

Target Price

$24.8

Current Price

$4.75

Analyzed by

7 Analysts

Target

$24.80

Intensity Therapeutics Inc. target price $24.8, a slight upside of 80.85% compared to current price of $4.75. According to 7 analysts rating.

Indian Investors' Interest in Intensity Therapeutics Inc. Stock

Search interest for Intensity Therapeutics Inc. Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 20, 2026 to July 20, 2026

Change:48% versus previous 30 day period

Intensity Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	0	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-4	-5	-3	-3	-3	-2	-2	-3	-2
EBITDA	-3	-4	-4	-3	-3	-3	-2	0	-3	-2
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-3	-4	-4	-3	-3	-3	-2	-2	-3	-2
Income Tax Expense	0	0	-	-	0	-	-	-	-	-
Net Income	-3	-4	-4	-3	-3	-3	-2	-2	-3	-2
Net Profit Margin	-1123.69%	0.00%	0.00%	0.00%	-13254.17%	0.00%	0.00%	0.00%	11734.62%	0.00%

Intensity Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0	0
Operating Income	-5	-6	-8	-7	-8	-16	-11
EBITDA	-5	-6	-8	-7	-10	-16	-11
Interest Expense	-	-	0	0	0	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-5	-6	-7	-7	-10	-16	-11
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-5	-5	-7	-7	-10	-16	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Intensity Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-4	-4	-3	-3	-3	-2	-2	-3	-2
Operating Cash Flow	-4	-4	-3	-2	-1	-2	-2	-2	-1
Investing Cash Flow	3	0	3	-9	-	-	-	-	-
Financing Cash Flow	0	0	0	2	0	3	7	7	0
Change in Cash	-1	-4	0	0	-1	1	4	4	-1

Intensity Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-7	-7	-10	-16	-11
Operating Cash Flow	-5	-6	-5	-7	-15	-9
Investing Cash Flow	4	-	-	-6	6	-
Financing Cash Flow	6	2	2	20	2	18
Change in Cash	5	-4	-3	7	-5	9

Global Institutional Holdings in Intensity Therapeutics Inc.

Funds	Holdings
Sentinus, LLC	0.86%
Goss Wealth Management LLC	0.04%
Sassicaia Capital Advisers LLC	0.02%
Atlantic Trust Group, LLC	0.01%
UBS Group AG	0.01%

See all

Insights on Intensity Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, INTS stock has moved up by 21.2%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 594.1% return, outperforming this stock by 691.0%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 427.6%

About Intensity Therapeutics Inc.

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Organisation	Intensity Therapeutics Inc.
Headquarters	1 Enterprise Drive, Shelton, CT, United States, 06484-4779
Industry	Biotechnology
CEO	Mr. Lewis H. Bender M.A., M.B.A., M.S.
E-voting on shares	Click here to vote

Key Management of Intensity Therapeutics Inc.

Name	Title
Mr. Lewis H. Bender M.A., M.B.A., M.S.	Founder, President, CEO & Chairman of the Board
Mr. Joseph Talamo CPA, M.B.A.	Chief Financial Officer
Mr. John Wesolowski CPA, M.B.A.	Principal Accounting Officer & Controller
Mr. James M. Ahlers	Executive Vice President of Corporate Finance

FAQs

What is Intensity Therapeutics Inc. share price today?

Intensity Therapeutics Inc. share price today is $4.75 as on July 20, 2026 at 8:45 am IST at the close of the market. Intensity Therapeutics Inc. share today touched a day high of $4.80 and a low of $4.57.

What is the 52 week high and 52 week low for Intensity Therapeutics Inc. share?

Intensity Therapeutics Inc. share touched a 52 week high of $43.50 on October 30, 2025 and a 52 week low of $3.51 on June 9, 2026. Intensity Therapeutics Inc. stock price today i.e. July 20, 2026 at 8:45 am IST is closed at $4.75,which is 89.08% down from its 52 week high and 35.33% up from its 52 week low.

What is Intensity Therapeutics Inc.'s market capitalisation today?

Intensity Therapeutics Inc. market capitalisation is $0.00T as on July 20, 2026 at 8:45 am IST.

How to invest in Intensity Therapeutics Inc. Stock (INTS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Intensity Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intensity Therapeutics Inc. Shares that will get you 0.3158 shares as per Intensity Therapeutics Inc. share price of $4.75 per share as on July 20, 2026 at 8:45 am IST.

What is the minimum amount required to buy Intensity Therapeutics Inc. Stock (INTS) from India?

Indian investors can start investing in Intensity Therapeutics Inc. (INTS) shares with as little as ₹96.28 or $1 (as of July 20, 2026 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Intensity Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 20, 2026 at 10:43 am IST). Based on Intensity Therapeutics Inc. share’s latest price of $4.75 as on July 20, 2026 at 8:45 am IST, you will get 2.1053 shares of Intensity Therapeutics Inc.. Learn more about fractional shares .